Holen Sie sich die Stockscreener-App
20.07
0.30%
-0.06
Handel nachbörslich:
20.07
Schlusskurs vom Vortag:
$20.13
Offen:
$19.99
24-Stunden-Volumen:
1.50M
Relative Volume:
2.11
Marktkapitalisierung:
$2.41B
Einnahmen:
$1.70B
Nettoeinkommen (Verlust:
$14.93M
KGV:
64.74
EPS:
0.31
Netto-Cashflow:
$87.89M
1W Leistung:
-4.25%
1M Leistung:
-3.46%
6M Leistung:
+19.61%
1J Leistung:
-12.59%
1-Tages-Spanne:
$19.89
$20.66
1-Wochen-Bereich:
$19.82
$21.95
52-Wochen-Spanne:
$15.92
$24.30
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Vergleichen Sie PRVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
20.07 | 2.41B | 1.70B | 14.93M | 87.89M | 0.12 |
|
VEEV
Veeva Systems Inc
|
224.15 | 36.39B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
66.83 | 11.55B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
57.83 | 10.80B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
94.95 | 8.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.82 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Bought by Franklin Resources Inc. - MarketBeat
Stifel Financial Corp Has $2.41 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
State Street Corp Sells 39,008 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group (NASDAQ:PRVA) Shares Down 5.2%Should You Sell? - MarketBeat
3 US Stocks That May Be Trading Below Their Estimated Value - Simply Wall St
Privia Health Group (NASDAQ:PRVA) Now Covered by Macquarie - Defense World
Macquarie sets shares price target on Privia Health, cites growth By Investing.com - Investing.com Australia
Macquarie Initiates Coverage on Privia Health Group (NASDAQ:PRVA) - MarketBeat
Macquarie sets shares price target on Privia Health, cites growth - Investing.com
Macquarie Initiates Coverage of Privia Health Group (PRVA) with Outperform Recommendation - MSN
Privia Health's SWOT analysis: navigating growth in a complex healthcare stock landscape - Investing.com Australia
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of “Buy” from Brokerages - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.79 Consensus Target Price from Brokerages - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Wellington Management Group LLP - MarketBeat
Pier Capital LLC Grows Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Holocene Advisors LP Sells 79,819 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Acquired by Charles Schwab Investment Management Inc. - MarketBeat
Soros Fund Management LLC Buys 150,000 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock Is Going Strong: Have Financials A Role To Play? - Simply Wall St
Privia Health Group Insiders Placed Bullish Bets Worth US$9.31m - Yahoo Finance
DH vs. PRVA: Which Stock Should Value Investors Buy Now? - Yahoo Finance
Intech Investment Management LLC Takes Position in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Bridgewater Associates LP Sells 45,829 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Fmr LLC Boosts Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Privia Health Group (NASDAQ:PRVA) Stock - Defense World
JPMorgan Chase & Co. Issues Positive Forecast for Privia Health Group (NASDAQ:PRVA) Stock Price - MarketBeat
Eventide Asset Management LLC Has $14.98 Million Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Dynamic Technology Lab Private Ltd Purchases New Shares in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
How the (PRVA) price action is used to our Advantage - Stock Traders Daily
Victory Capital Management Inc. Raises Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Position Lifted by Victory Capital Management Inc. - MarketBeat
Icon Wealth Advisors LLC Has $5.48 Million Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health price target raised to $21 from $19 at Barclays - MSN
Brokerages Set Privia Health Group, Inc. (NASDAQ:PRVA) PT at $25.07 - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Recommendation of “Buy” from Analysts - Defense World
DH or PRVA: Which Is the Better Value Stock Right Now? - Yahoo Finance
Privia Health Group, Inc. (NASDAQ:PRVA) Position Reduced by Amalgamated Bank - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Purchased by GSA Capital Partners LLP - MarketBeat
Durable Capital Partners LP Bolsters Stake in Privia Health Grou - GuruFocus.com
Where are the Opportunities in (PRVA) - Stock Traders Daily
Privia Health's SWOT analysis: balanced growth in challenging healthcare stock market - Investing.com Nigeria
Some May Be Optimistic About Privia Health Group's (NASDAQ:PRVA) Earnings - Yahoo Finance
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by US Bancorp DE - Defense World
FMR LLC's Strategic Acquisition in Privia Health Group Inc - GuruFocus.com
Privia Health Group (NASDAQ:PRVA) Given New $21.00 Price Target at Barclays - Defense World
Principal Financial Group Inc. Has $59.23 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Earnings call: Privia Health reports robust Q3 growth, raises 2024 outlook - Investing.com
Privia Health Group Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Privia Health Group, Inc. (NASDAQ:PRVA) Q3 2024 Earnings Call Transcript - Insider Monkey
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):